Pliant Therapeutics Inc (PLRX)
13.81
0.00 (0.00%)
USD |
NASDAQ |
May 10, 16:00
13.81
0.00 (0.00%)
After-Hours: 20:00
Pliant Therapeutics Cash from Investing (TTM): 106.74M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 106.74M |
December 31, 2023 | -127.01M |
September 30, 2023 | -138.91M |
June 30, 2023 | -355.42M |
March 31, 2023 | -325.94M |
December 31, 2022 | -150.20M |
September 30, 2022 | -144.44M |
June 30, 2022 | 65.91M |
March 31, 2022 | 63.00M |
Date | Value |
---|---|
December 31, 2021 | 73.70M |
September 30, 2021 | 59.82M |
June 30, 2021 | -77.36M |
March 31, 2021 | -187.26M |
December 31, 2020 | -210.87M |
September 30, 2020 | -231.95M |
June 30, 2020 | -113.13M |
March 31, 2020 | -1.887M |
December 31, 2019 | -17.93M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-355.42M
Minimum
Jun 2023
106.74M
Maximum
Mar 2024
-95.17M
Average
-120.07M
Median
Cash from Investing (TTM) Benchmarks
Masimo Corp | -89.00M |
Liquidia Corp | -11.29M |
Vor Biopharma Inc | 71.01M |
CEL-SCI Corp | -0.3835M |
AIM ImmunoTech Inc | -0.832M |